Top Story

Hydroxyurea appears safe for African children with sickle cell anemia

Hydroxyurea appears safe for African children with sickle cell anemia
October 19, 2017

Hydroxyurea did not increase the risk for malaria infection in children with sickle cell anemia who live in malaria-endemic regions of Uganda, according to the results of a randomized, double-blind clinical trial published in Blood.

“Hydroxyurea has proven laboratory and clinical efficacy for children and adults with sickle cell anemia living in the United States and Europe,” Russell E. Ware, MD, PhD, director of the division of hematology at Cincinnati Children’s Hospital Medical Center, told HemOnc Today. “However, there are virtually no data regarding its safety and toxicities in sub-Saharan Africa, which bears the greatest global burden of disease.”

In the Journals Plus

Mortality risk greater for male transfusion recipients with previously pregnant donor

October 17, 2017
Men who received red blood cell transfusions from women who had ever been pregnant appeared to have an increased risk for death, according to results of a large…

Seven important updates for World Thrombosis Day

October 13, 2017
World Thrombosis Day is observed today to increase global awareness about the condition, including its causes, risk factors, symptoms, and prevention and treatment…

Discuss goals, limitations with patients seeking direct-to-consumer genetic tests

October 5, 2017
Humans are born with a risk for developing, at some point in their life, one of more than 40 disorders that clinicians have identified to have some connection with…
More Headlines »

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »

VIDEO: Array of FDA myeloma drug approvals, new research steer field in filling ‘unmet medical need’

June 2, 2016
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress


Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »